Androgen insensitivity syndrome

Seminars in Reproductive Medicine

Volumn 30, Issue 5, 2012, Pages 432-442

  Hughes, Ieuanarwel ^a   Werner, Ralf ^b   Bunch, Trevor ^a   Hiort, Olaf ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

androgen insensitivity; androgen receptor; disclosure; germ cell tumors; hormone replacement; mutations

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; ESTRADIOL; ETHINYLESTRADIOL; GLUCOCORTICOID RECEPTOR; LUTEINIZING HORMONE; MINERALOCORTICOID RECEPTOR; PROGESTERONE RECEPTOR; SEX HORMONE BINDING GLOBULIN; STEROIDOGENIC ACUTE REGULATORY PROTEIN; TESTOSTERONE;

ANDROGEN INSENSITIVITY SYNDROME; ARTICLE; BREAST RECONSTRUCTION; COMPLETE ANDROGEN INSENSITIVITY SYNDROME; DIFFERENTIAL DIAGNOSIS; DILATION AND EVACUATION; DISEASE ASSOCIATION; DISTRESS SYNDROME; DRUG DOSE INCREASE; EMBRYO DEVELOPMENT; ESTROGEN THERAPY; EXON; FEMALE; FEMALE INFERTILITY; FETUS DEVELOPMENT; GENE MUTATION; GENETIC CODE; GERM CELL TUMOR; GONAD DEVELOPMENT; GONADECTOMY; GYNECOMASTIA; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HYPOSPADIAS; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MICROPENIS; MILD ANDROGEN INSENSITIVITY SYNDROME; NONHUMAN; PARTIAL ANDROGEN INSENSITIVITY SYNDROME; PATHOPHYSIOLOGY; PATIENT ADVOCACY; PATIENT COUNSELING; PHENOTYPE; PRIMARY AMENORRHEA; PROTEIN BLOOD LEVEL; PSYCHOLOGIC ASSESSMENT; PSYCHOSOCIAL CARE; ROKITANSKY SYNDROME; SEX DIFFERENTIATION DISORDER; X CHROMOSOME;

ANDROGEN-INSENSITIVITY SYNDROME; ANDROGENS; ANIMALS; FETAL DEVELOPMENT; HUMANS; MALE; MUTATION; PATIENT ADVOCACY; PATIENT CARE TEAM; PROTEIN STRUCTURE, TERTIARY; QUALITY OF LIFE; RECEPTORS, ANDROGEN; SEVERITY OF ILLNESS INDEX; TESTIS;

EID: 84866998758     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0032-1324728     Document Type: Article

References (106)

1. Jameson L. J. Hormone resistance syndromes. Human Press: 1999; 1 281
2. Hughes I. A., Davies J. D., Bunch T. I., Pasterski V., Mastroyannopoulou K., Macdougall J. Androgen insensitivity syndrome. Lancet: 2012;; In press
3. Morris J. M. The syndrome of testicular feminization in male pseudohermaphrodites. Am J Obstet Gynecol: 1953; 65 6 1192 1211
4. Quigley C. A., De Bellis A., Marschke K. B., el-Awady M. K., Wilson E. M., French F. S. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev: 1995; 16 3 271 321
5. Yamada G., Suzuki K., Haraguchi R., et al. Molecular genetic cascades for external genitalia formation: an emerging organogenesis program. Dev Dyn: 2006; 235 7 1738 1752
6. Kurzrock E. A., Baskin L. S., Li Y., Cunha G. R. Epithelial-mesenchymal interactions in development of the mouse fetal genital tubercle. Cells Tissues Organs: 1999; 164 3 125 130
7. Welsh M., Saunders P. T., Fisken M., et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest: 2008; 118 4 1479 1490
8. Miyagawa S., Satoh Y., Haraguchi R., et al. Genetic interactions of the androgen and Wnt/beta-catenin pathways for the masculinization of external genitalia. Mol Endocrinol: 2009; 23 6 871 880
9. Song L. N., Herrell R., Byers S., Shah S., Wilson E. M., Gelmann E. P. Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription. Mol Cell Biol: 2003; 23 5 1674 1687
10. Miyagawa S., Matsumaru D., Murashima A., et al. The role of sonic hedgehog-Gli2 pathway in the masculinization of external genitalia. Endocrinology: 2011; 152 7 2894 2903
11. Zhou X. Roles of androgen receptor in male and female reproduction: lessons from global and cell-specific androgen receptor knockout (ARKO) mice. J Androl: 2010; 31 3 235 243
12. Bay K., Main K. M., Toppari J., Skakkebæk N. E.; Medscape. Testicular descent: INSL3, testosterone, genes and the intrauterine milieu. Nat Rev Urol: 2011; 8 4 187 196
13. Chamberlain N. L., Whitacre D. C., Miesfeld R. L. Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain. J Biol Chem: 1996; 271 43 26772 26778
14. Lavery D. N., McEwan I. J. Structural characterization of the native NH2-terminal transactivation domain of the human androgen receptor: a collapsed disordered conformation underlies structural plasticity and protein-induced folding. Biochemistry: 2008; 47 11 3360 3369
15. Chamberlain N. L., Driver E. D., Miesfeld R. L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res: 1994; 22 15 3181 3186
16. Werner R., Holterhus P. M., Binder G., et al. The A645D mutation in the hinge region of the human androgen receptor (AR) gene modulates AR activity, depending on the context of the polymorphic glutamine and glycine repeats. J Clin Endocrinol Metab: 2006; 91 9 3515 3520
17. La Spada A. R., Wilson E. M., Lubahn D. B., Harding A. E., Fischbeck K. H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature: 1991; 352 6330 77 79
18. Matias P. M., Donner P., Coelho R., et al. Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. J Biol Chem: 2000; 275 34 26164 26171
19. Shaffer P. L., Jivan A., Dollins D. E., Claessens F., Gewirth D. T. Structural basis of androgen receptor binding to selective androgen response elements. Proc Natl Acad Sci U S A: 2004; 101 14 4758 4763
20. Helsen C., Kerkhofs S., Clinckemalie L., et al. Structural basis for nuclear hormone receptor DNA binding. Mol Cell Endocrinol: 2012; 348 2 411 417
21. Mangelsdorf D. J., Thummel C., Beato M., et al. The nuclear receptor superfamily: the second decade. Cell: 1995; 83 6 835 839
22. De Bruyn R., Bollen R., Claessens F. Identification and characterization of androgen response elements. Methods Mol Biol: 2011; 776 81 93
23. Jenster G., Trapman J., Brinkmann A. O. Nuclear import of the human androgen receptor. Biochem J: 1993; 293 Pt 3 761 768
24. Cutress M. L., Whitaker H. C., Mills I. G., Stewart M., Neal D. E. Structural basis for the nuclear import of the human androgen receptor. J Cell Sci: 2008; 121 Pt 7 957 968
25. Schauwaers K., De Gendt K., Saunders P. T., et al. Loss of androgen receptor binding to selective androgen response elements causes a reproductive phenotype in a knockin mouse model. Proc Natl Acad Sci U S A: 2007; 104 12 4961 4966
26. Moras D., Gronemeyer H. The nuclear receptor ligand-binding domain: structure and function. Curr Opin Cell Biol: 1998; 10 3 384 391
27. He B., Wilson E. M. Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs. Mol Cell Biol: 2003; 23 6 2135 2150
28. Jääskeläinen J. Molecular biology of androgen insensitivity. Mol Cell Endocrinol: 2012; 352 12 4 12
29. Boehmer A. L., Brinkmann O., Brüggenwirth H., et al. Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab: 2001; 86 9 4151 4160
30. Sarpel U., Palmer S. K., Dolgin S. E. The incidence of complete androgen insensitivity in girls with inguinal hernias and assessment of screening by vaginal length measurement. J Pediatr Surg: 2005; 40 1 133 136, discussion 136137
31. Hurme T., Lahdes-Vasama T., Mäkela E., Iber T., Toppari J. Clinical findings in prepubertal girls with inguinal hernia with special reference to the diagnosis of androgen insensitivity syndrome. Scand J Urol Nephrol: 2009; 43 1 42 46
32. Deeb A., Hughes I. A. Inguinal hernia in female infants: a cue to check the sex chromosomes? BJU Int: 2005; 96 3 401 403
33. Yalinkaya A., Yayla M., Erdemoglu M. Prenatal diagnosis of a fetus with androgen insensitivity syndrome (AIS). Prenat Diagn: 2007; 27 9 856 857
34. Stewart C. JR, Baker E., Beaton C., Crook M., Peverall J., Wallace S. Detection of Y-chromosome in gonadal tumours using fluorescence in situ hybridization: diagnostic value in intersex conditions including older patients with clinically unsuspected androgen insensitivity syndrome. Histopathology: 2008; 52 2 175 182
35. Danilovic D. LS, Correa P. HS, Costa E. MF, Melo K. FS, Mendonca B. B., Arnhold I. JP. Height and bone mineral density in androgen insensitivity syndrome with mutations in the androgen receptor gene. Osteoporos Int: 2007; 18 3 369 374
36. Han T. S., Goswami D., Trikudanathan S., Creighton S. M., Conway G. S. Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis. Eur J Endocrinol: 2008; 159 2 179 185
37. Gudbjartsson D. F., Walters G. B., Thorleifsson G., et al. Many sequence variants affecting diversity of adult human height. Nat Genet: 2008; 40 5 609 615
38. Miles H. L., Gidlöf S., Nordenström A., Ong K. K., Hughes I. A. The role of androgens in fetal growth: observational study in two genetic models of disordered androgen signalling. Arch Dis Child Fetal Neonatal Ed: 2010; 95 6 F435 F438
39. Melo K. FS, Mendonca B. B., Billerbeck A. EC., et al. Clinical, hormonal, behavioral, and genetic characteristics of androgen insensitivity syndrome in a Brazilian cohort: five novel mutations in the androgen receptor gene. J Clin Endocrinol Metab: 2003; 88 7 3241 3250
40. Hughes I. A., Deeb A. Androgen resistance. Best Pract Res Clin Endocrinol Metab: 2006; 20 4 577 598
41. Sinnecker G. H., Hiort O., Nitsche E. M., Holterhus P. M., Kruse K.; German Collaborative Intersex Study Group. Functional assessment and clinical classification of androgen sensitivity in patients with mutations of the androgen receptor gene. Eur J Pediatr: 1997; 156 1 7 14
42. Bouvattier C., Carel J. C., Lecointre C., et al. Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. J Clin Endocrinol Metab: 2002; 87 1 29 32
43. Quigley C. A. Editorial: The postnatal gonadotropin and sex steroid surge-insights from the androgen insensitivity syndrome. J Clin Endocrinol Metab: 2002; 87 1 24 28
44. Bergadá I., Milani C., Bedecarrás P., et al. Time course of the serum gonadotropin surge, inhibins, and anti-Müllerian hormone in normal newborn males during the first month of life. J Clin Endocrinol Metab: 2006; 91 10 4092 4098
45. Ahmed S. F., Keir L., McNeilly J., Galloway P., O'Toole S., Wallace A. M. The concordance between serum anti-Mullerian hormone and testosterone concentrations depends on duration of hCG stimulation in boys undergoing investigation of gonadal function. Clin Endocrinol (Oxf): 2010; 72 6 814 819
46. Rey R. A., Belville C., Nihoul-Fékété C., et al. Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement. J Clin Endocrinol Metab: 1999; 84 2 627 631
47. Chemes H. E., Rey R. A., Nistal M., et al. Physiological androgen insensitivity of the fetal, neonatal, and early infantile testis is explained by the ontogeny of the androgen receptor expression in Sertoli cells. J Clin Endocrinol Metab: 2008; 93 11 4408 4412
48. Boukari K., Meduri G., Brailly-Tabard S., et al. Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Mullerian hormone repression during early human testis development. J Clin Endocrinol Metab: 2009; 94 5 1818 1825
49. Michala L., Goswami D., Creighton S. M., Conway G. S. Swyer syndrome: presentation and outcomes. BJOG: 2008; 115 6 737 741
50. Pittock S. T., Babovic-Vuksanovic D., Lteif A. Mayer-Rokitansky- Küster-Hauser anomaly and its associated malformations. Am J Med Genet A: 2005; 135 3 314 316
51. Philibert P., Biason-Lauber A., Gueorguieva I., et al. Molecular analysis of WNT4 gene in four adolescent girls with mullerian duct abnormality and hyperandrogenism (atypical Mayer-Rokitansky-Küster-Hauser syndrome). Fertil Steril: 2011; 95 8 2683 2686 Epub ahead of print
52. Lee Y. S., Kirk J. M., Stanhope R. G., et al. Phenotypic variability in 17beta-hydroxysteroid dehydrogenase-3 deficiency and diagnostic pitfalls. Clin Endocrinol (Oxf): 2007; 67 1 20 28
53. Imperato-McGinley J. 5alpha-reductase-2 deficiency and complete androgen insensitivity: lessons from nature. Adv Exp Med Biol: 2002; 511 121 131, discussion 131134
54. Huhtaniemi I., Alevizaki M. Gonadotrophin resistance. Best Pract Res Clin Endocrinol Metab: 2006; 20 4 561 576
55. Miller W. L., Auchus R. J. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev: 2011; 32 1 81 151
56. Rosa S., Duff C., Meyer M., et al. P450c17 deficiency: clinical and molecular characterization of six patients. J Clin Endocrinol Metab: 2007; 92 3 1000 1007
57. Faisal S. F., Achermann J. C., Arlt W., et al. UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development. Clin Endocrinol (Oxf): 2011
58. Zuccarello D., Ferlin A., Vinanzi C., et al. Detailed functional studies on androgen receptor mild mutations demonstrate their association with male infertility. Clin Endocrinol (Oxf): 2008; 68 4 580 588
59. Yong E. L., Ng S. C., Roy A. C., Yun G., Ratnam S. S. Pregnancy after hormonal correction of severe spermatogenic defect due to mutation in androgen receptor gene. Lancet: 1994; 344 8925 826 827
60. Wang R. S., Yeh S., Tzeng C. R., Chang C. Androgen receptor roles in spermatogenesis and fertility: lessons from testicular cell-specific androgen receptor knockout mice. Endocr Rev: 2009; 30 2 119 132
61. Werner R., Zhan J., Gesing J., Struve D., Hiort O. In-vitro characterization of androgen receptor mutations associated with complete androgen insensitivity syndrome reveals distinct functional deficits. Sex Dev: 2008; 2 2 73 83
62. Hellwinkel O. J., Holterhus P. M., Struve D., Marschke C., Homburg N., Hiort O. A unique exonic splicing mutation in the human androgen receptor gene indicates a physiologic relevance of regular androgen receptor transcript variants. J Clin Endocrinol Metab: 2001; 86 6 2569 2575
63. Werner R., Schütt J., Hannema S., et al. Androgen receptor gene mutations in androgen insensitivity syndrome cause distinct patterns of reduced activation of androgen-responsive promoter constructs. J Steroid Biochem Mol Biol: 2006; 101 1 1 10
64. Boehmer A. L., Brinkmann O., Brüggenwirth H., et al. Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab: 2001; 86 9 4151 4160
65. Holterhus P. M., Brüggenwirth H. T., Brinkmann A. O., Hiort O. Post-zygotic mutations and somatic mosaicism in androgen insensitivity syndrome. Trends Genet: 2001; 17 11 627 628
66. Köhler B., Lumbroso S., Leger J., et al. Androgen insensitivity syndrome: somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling. J Clin Endocrinol Metab: 2005; 90 1 106 111
67. Bebermeier J. H., Brooks J. D., DePrimo S. E., et al. Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription. J Mol Med (Berl): 2006; 84 11 919 931
68. Tadokoro R., Bunch T., Schwabe J. W., Hughes I. A., Murphy J. C. Comparison of the molecular consequences of different mutations at residue 754 and 690 of the androgen receptor (AR) and androgen insensitivity syndrome (AIS) phenotype. Clin Endocrinol (Oxf): 2009; 71 2 253 260
69. Holterhus P. M., Hiort O., Demeter J., Brown P. O., Brooks J. D. Differential gene-expression patterns in genital fibroblasts of normal males and 46,XY females with androgen insensitivity syndrome: evidence for early programming involving the androgen receptor. Genome Biol: 2003; 4 6 R37
70. Holterhus P. M., Bebermeier J. H., Werner R., et al. Disorders of sex development expose transcriptional autonomy of genetic sex and androgen-programmed hormonal sex in human blood leukocytes. BMC Genomics: 2009; 10 292
71. Appari M., Werner R., Wünsch L., et al. Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome. J Mol Med (Berl): 2009; 87 6 623 632
72. Hughes I. A., Houk C., Ahmed S. F., Lee P. A.; LWPES Consensus Group; ESPE Consensus Group. Consensus statement on management of intersex disorders. Arch Dis Child: 2006; 91 7 554 563
73. Hannema S. E., Scott I. S., Rajpert-De Meyts E., Skakkebaek N. E., Coleman N., Hughes I. A. Testicular development in the complete androgen insensitivity syndrome. J Pathol: 2006; 208 4 518 527
74. Looijenga L. HJ, Hersmus R., Oosterhuis J. W., Cools M., Drop S. LS, Wolffenbuttel K. P. Tumor risk in disorders of sex development (DSD). Best Pract Res Clin Endocrinol Metab: 2007; 21 3 480 495
75. Bertelloni S., Dati E., Baroncelli G. I., Hiort O. Hormonal management of complete androgen insensitivity syndrome from adolescence onward. Horm Res Paediatr: 2011; 76 6 428 433
76. Foradori C. D., Weiser M. J., Handa R. J. Non-genomic actions of androgens. Front Neuroendocrinol: 2008; 29 2 169 181
77. Danilovic D. L., Correa P. H., Costa E. M., Melo K. F., Mendonca B. B., Arnhold I. J. Height and bone mineral density in androgen insensitivity syndrome with mutations in the androgen receptor gene. Osteoporos Int: 2007; 18 3 369 374
78. Bertelloni S., Baroncelli G. I., Mora S. Bone health in disorders of sex differentiation. Sex Dev: 2010; 4 45 270 284
79. Han T. S., Goswami D., Trikudanathan S., Creighton S. M., Conway G. S. Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis. Eur J Endocrinol: 2008; 159 2 179 185
80. Rutgers J. L., Scully R. E. The androgen insensitivity syndrome (testicular feminization): a clinicopathologic study of 43 cases. Int J Gynecol Pathol: 1991; 10 2 126 144
81. Deans R., Creighton S. M., Liao L. M., Conway G. S. Timing of gonadectomy in adult women with complete androgen insensitivity syndrome (CAIS): patient preferences and clinical evidence. Clin Endocrinol (Oxf): 2012; 76 6 894 898
82. Looijenga L. HJ, Hersmus R., de Leeuw B. HCGM., et al. Gonadal tumours and DSD. Best Pract Res Clin Endocrinol Metab: 2010; 24 2 291 310
83. Rajpert-de Meyts E., Hoei-Hansen C. E. From gonocytes to testicular cancer: the role of impaired gonadal development. Ann N Y Acad Sci: 2007; 1120 168 180
84. Looijenga L. H., Gillis A. J., Stoop H., Biermann K., Oosterhuis J. W. Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance. Int J Androl: 2011; 34 4 Pt 2 e234 e251
85. Ismail-Pratt I. S., Bikoo M., Liao L. M., Conway G. S., Creighton S. M. Normalization of the vagina by dilator treatment alone in Complete Androgen Insensitivity Syndrome and Mayer-Rokitansky-Kuster-Hauser Syndrome. Hum Reprod: 2007; 22 7 2020 2024
86. Purves J. T., Miles-Thomas J., Migeon C., Gearhart J. P. Complete androgen insensitivity: the role of the surgeon. J Urol: 2008; 180 4, Suppl 1716 1719
87. Crouch N. S., Michala L., Creighton S. M., Conway G. S. Androgen-dependent measurements of female genitalia in women with complete androgen insensitivity syndrome. BJOG: 2011; 118 1 84 87
88. Wilson J. M., Arnhym A., Champeau A., Ebbers M., Coakley F., Baskin L. Complete androgen insensitivity syndrome: an anatomic evaluation and sexual function questionnaire pilot study. J Pediatr Urol: 2011; 7 4 416 421
89. Liao L-M. Learning to assist women with atypical genitalia: journey through ignorance, taboo and dilemma. J Reprod Infant Psychol: 2003; 21 229 238
90. Pasterski V., Prentice P., Hughes I. A. Consequences of the Chicago consensus on disorders of sex development (DSD): current practice in Europe. Arch Dis Child: 2010; 95 618 623
91. Shah R., Woolley M. M., Costin G. Testicular feminization: the androgen insensitivity syndrome. J Pediatr Surg: 1992; 27 6 757 760
92. Jorgensen P. B., Kjartansdóttir K. R., Fedder J. Care of women with XY karyotype: a clinical practice guideline. Fertil Steril: 2010; 94 1 105 113
93. Liao L-M, Tacconelli E., Wood D., Conway G., Creighton S. M. Adolescent girls with disorders of sex development: A needs analysis of transitional care. J Pediatr Urol: 2010; 6 6 609 613
94. Slijper F. M., Frets P. G., Boehmer A. L., Drop S. L., Niermeijer M. F. Androgen insensitivity syndrome (AIS): emotional reactions of parents and adult patients to the clinical diagnosis of AIS and its confirmation by androgen receptor gene mutation analysis. Horm Res: 2000; 53 1 9 15
95. Goodall J. Helping a child to understand her own testicular feminisation. Lancet: 1991; 337 8732 33 35
96. Hines M., Ahmed S. F., Hughes I. A. Psychological outcomes and gender-related development in complete androgen insensitivity syndrome. Arch Sex Behav: 2003; 32 2 93 101
97. Cohen-Kettenis P. T. Psychosocial and psychosexual aspects of disorders of sex development. Best Pract Res Clin Endocrinol Metab: 2010; 24 2 325 334
98. Minto C. L., Liao K. L., Conway G. S., Creighton S. M. Sexual function in women with complete androgen insensitivity syndrome. Fertil Steril: 2003; 80 1 157 164
99. Hughes I. A. Early management and gender assignment in disorders of sexual differentiation. Endocr Dev: 2007; 11 47 57
100. Ahmed S. F., Khwaja O., Hughes I. A. The role of a clinical score in the assessment of ambiguous genitalia. BJU Int: 2000; 85 1 120 124
101. Poujol N., Lobaccaro J. M., Chiche L., Lumbroso S., Sultan C. Functional and structural analysis of R607Q and R608K androgen receptor substitutions associated with male breast cancer. Mol Cell Endocrinol: 1997; 130 12 43 51
102. Davis S. E., Wallace A. M. A 19year old with complete androgen insensitivity syndrome and juvenile fibroadenoma of the breast. Breast J: 2001; 7 6 430 433
103. Cools M., Drop S. LS, Wolffenbuttel K. P., Oosterhuis J. W., Looijenga L. HJ. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev: 2006; 27 5 468 484
104. Bouvattier C., Mignot B., Lefèvre H., Morel Y., Bougnères P. Impaired sexual activity in male adults with partial androgen insensitivity. J Clin Endocrinol Metab: 2006; 91 9 3310 3315
105. Brain C. E., Creighton S. M., Mushtaq I., et al. Holistic management of DSD. Best Pract Res Clin Endocrinol Metab: 2010; 24 2 335 354
106. Houk C. P., Lee P. A. Update on disorders of sex development. Curr Opin Endocrinol Diabetes Obes: 2012; 19 1 28 32